Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

about

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

Item

http://www.wikidata.org/entity/Q50238394

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@en

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@nl

type

Item

label

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@en

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@nl

prefLabel

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@en

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@nl

P1476

Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.

@en

P2093

Hidekata Yasuoka

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Akiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.

TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

Idiopathic multicentric Castleman's disease: a systematic literature review.

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

P304

2117-2119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-017-3111-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsutomu Takeuchi

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28861599

http://www.w3.org/2001/XMLSchema#string